Ourania N. Kostopoulou

karolinska institutet

H指数:17

被引数:564

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Dual PI3K/AKT and CDK4/6 inhibition reveals selective sensitivity in an SHH medulloblastoma stem cell model

双PI3K/AKT和CDK4/6抑制在SHH髓母细胞瘤干细胞模型中显示出选择性敏感性

Molecular Oncology

IF4.5

2026-02-240

OAAI

Fibroblast Supernatants Modulate Treatment Responses in Human Papillomavirus Positive and Negative Oropharyngeal Cancer Cell Lines

ANTICANCER RESEARCH

IF1.7

2025-11-010

PRE

Therapeutic options for human papillomavirus-positive tonsil and base of tongue cancer

人乳头瘤病毒阳性扁桃体和舌根癌的疗法选择

JOURNAL OF INTERNAL MEDICINE

IF9.2

2025-04-170

OAAI

Enhancing targeted therapy by combining PI3K and AKT inhibitors with or without cisplatin or vincristine in medulloblastoma cell lines in vitro

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2024-11-010

OAAI

Combined targeted therapy with PI3K and CDK4/6, or FGFR inhibitors show synergistic effects in a neuroblastoma spheroid culture model

PI3K和CDK4/6或FGFR抑制剂联合靶向治疗在神经母细胞瘤球体培养模型中显示协同作用

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2024-08-011

OAAI

Human papillomavirus (HPV) load is higher in HPVDNA/p16 positive than in HPVDNA positive/p16 negative oropharyngeal squamous cell carcinoma but does not differ significantly between various subsites or correlate to survival

HPVDNA/p16阳性的人乳头瘤病毒 (HPV) 载量高于HPVDNA阳性/p16阴性的口咽鳞状细胞癌，但在各个亚位点之间没有显着差异或与生存相关

ORAL ONCOLOGY

IF3.9

2024-04-011

OAAI

Efficacy of combined targeted therapy with PI3K and CDK4/6 or PARP and WEE1 inhibitors in neuroblastoma cell lines

ONCOLOGY REPORTS

IF3.9

2023-07-192

OAAI

Combination of PARP and WEE1 inhibitors in vitro: Potential for use in the treatment of SHH medulloblastoma

ONCOLOGY REPORTS

IF3.9

2023-05-057

OAAI

Targeted Therapy of HPV Positive and Negative Tonsillar Squamous Cell Carcinoma Cell Lines Reveals Synergy between CDK4/6, PI3K and Sometimes FGFR Inhibitors, but Rarely between PARP and WEE1 Inhibitors

VIRUSES-BASEL

IF3.5

2022-06-239

OAAI

Targeting PI3K, FGFR, CDK4/6 Signaling Pathways Together With Cytostatics and Radiotherapy in Two Medulloblastoma Cell Lines

FRONTIERS IN ONCOLOGY

IF3.3

2021-09-2411

OAAI

Human Cytomegalovirus Reduces Endothelin-1 Expression in Both Endothelial and Vascular Smooth Muscle Cells

MICROORGANISMS

IF4.2

2021-05-256

OAAI

Prognostic Markers and Driver Genes and Options for Targeted Therapy in Human-Papillomavirus-Positive Tonsillar and Base-of-Tongue Squamous Cell Carcinoma

VIRUSES-BASEL

IF3.5

2021-05-1419

OAAI

Targeted Therapy With PI3K and FGFR Inhibitors on Human Papillomavirus Positive and Negative Tonsillar and Base of Tongue Cancer Lines With and Without Corresponding Mutations

FRONTIERS IN ONCOLOGY

IF3.3

2021-05-1126

OAAI

Human Cytomegalovirus Infection Induces High Expression of Prolactin and Prolactin Receptors in Ovarian Cancer

BIOLOGY-BASEL

IF3.5

2020-02-2712

OAAI

Glucocorticoids promote a glioma stem cell-like phenotype and resistance to chemotherapy in human glioblastoma primary cells: Biological and prognostic significance

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2017-11-0732

OAAI

Direct infection of primary endothelial cells with human cytomegalovirus prevents angiogenesis and migration

JOURNAL OF GENERAL VIROLOGY

IF4.3

2015-12-0113

Synthesis and antimicrobial activity of chloramphenicol-polyamine conjugates

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2015-07-0122

PREAI

Conjugation with polyamines enhances the antibacterial and anticancer activity of chloramphenicol

NUCLEIC ACIDS RESEARCH

IF13.1

2014-06-1741

OAAI

Investigating the entire course of telithromycin binding to Escherichia coli ribosomes

NUCLEIC ACIDS RESEARCH

IF13.1

2012-02-2216

OAAI

Ourania N. Kostopoulou

个人简介

教育背景

工作经历

荣誉奖项

研究方向